<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Aleksandrova K</submitter><funding>Cancer Research UK</funding><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><pagination>djv010</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4402364</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>107(4)</volume><pubmed_abstract>Neopterin may be relevant for colorectal cancer (CRC) development, as a biomarker of cellular immune activity exerting pleiotropic effects on cellular ageing, oxidative stress, and inflammation. So far, the association between prediagnostic neopterin and colon and rectal cancer risk has not been evaluated in human populations. A nested case-control study was conducted within the European Prospective Investigation into Cancer and Nutrition cohort using data on plasma concentrations of total neopterin (T-N, sum of neopterin and 7,8-dihydroneopterin) in 830 incident CRC case patients (561 colon and 269 rectal) matched within risk sets to 830 control participants. A subsequent replication study used data from the Hordaland Health Study, where 173 CRC case patients have been diagnosed among 659</pubmed_abstract><journal>Journal of the National Cancer Institute</journal><pubmed_title>A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk.</pubmed_title><pmcid>PMC4402364</pmcid><funding_grant_id>MC_UU_12015/1</funding_grant_id><funding_grant_id>G1000143</funding_grant_id><funding_grant_id>NF-SI-0512-10135</funding_grant_id><funding_grant_id>NF-SI-0512-10114</funding_grant_id><funding_grant_id>G0401527</funding_grant_id><funding_grant_id>16491</funding_grant_id><funding_grant_id>MC_U106179471</funding_grant_id><pubmed_authors>Palli D</pubmed_authors><pubmed_authors>Cross AJ</pubmed_authors><pubmed_authors>Lu Y</pubmed_authors><pubmed_authors>Boeing H</pubmed_authors><pubmed_authors>Kaaks R</pubmed_authors><pubmed_authors>Severi G</pubmed_authors><pubmed_authors>Fedirko V</pubmed_authors><pubmed_authors>Racine A</pubmed_authors><pubmed_authors>Freisling H</pubmed_authors><pubmed_authors>Khaw KT</pubmed_authors><pubmed_authors>Trichopoulos D</pubmed_authors><pubmed_authors>Trichopoulou A</pubmed_authors><pubmed_authors>Sieri S</pubmed_authors><pubmed_authors>Vollset SE</pubmed_authors><pubmed_authors>Ueland PM</pubmed_authors><pubmed_authors>Tjonneland A</pubmed_authors><pubmed_authors>Weiderpass E</pubmed_authors><pubmed_authors>Boutron-Ruault MC</pubmed_authors><pubmed_authors>Tell GS</pubmed_authors><pubmed_authors>Chirlaque MD</pubmed_authors><pubmed_authors>May AM</pubmed_authors><pubmed_authors>Ljuslinder I</pubmed_authors><pubmed_authors>Kuhn T</pubmed_authors><pubmed_authors>Lagiou P</pubmed_authors><pubmed_authors>Wareham NJ</pubmed_authors><pubmed_authors>Midttun O</pubmed_authors><pubmed_authors>Gunter MJ</pubmed_authors><pubmed_authors>Riboli E</pubmed_authors><pubmed_authors>Jakszyn P</pubmed_authors><pubmed_authors>Palmqvist R</pubmed_authors><pubmed_authors>Jenab M</pubmed_authors><pubmed_authors>Overvad K</pubmed_authors><pubmed_authors>Sanchez MJ</pubmed_authors><pubmed_authors>Tumino R</pubmed_authors><pubmed_authors>Ardanaz E</pubmed_authors><pubmed_authors>Bueno-de-Mesquita B</pubmed_authors><pubmed_authors>Vineis P</pubmed_authors><pubmed_authors>Panico S</pubmed_authors><pubmed_authors>Quiros JR</pubmed_authors><pubmed_authors>Aleksandrova K</pubmed_authors><pubmed_authors>Kong SY</pubmed_authors><pubmed_authors>Dorronsoro M</pubmed_authors><pubmed_authors>Zuo H</pubmed_authors><pubmed_authors>Chuang SC</pubmed_authors><pubmed_authors>Pischon T</pubmed_authors><pubmed_authors>Johansson M</pubmed_authors><pubmed_authors>Travis RC</pubmed_authors></additional><is_claimable>false</is_claimable><name>A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk.</name><description>Neopterin may be relevant for colorectal cancer (CRC) development, as a biomarker of cellular immune activity exerting pleiotropic effects on cellular ageing, oxidative stress, and inflammation. So far, the association between prediagnostic neopterin and colon and rectal cancer risk has not been evaluated in human populations. A nested case-control study was conducted within the European Prospective Investigation into Cancer and Nutrition cohort using data on plasma concentrations of total neopterin (T-N, sum of neopterin and 7,8-dihydroneopterin) in 830 incident CRC case patients (561 colon and 269 rectal) matched within risk sets to 830 control participants. A subsequent replication study used data from the Hordaland Health Study, where 173 CRC case patients have been diagnosed among 659</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Apr</publication><modification>2025-04-19T00:47:53.716Z</modification><creation>2019-03-27T01:50:07Z</creation></dates><accession>S-EPMC4402364</accession><cross_references><pubmed>25713165</pubmed><doi>10.1093/jnci/djv010</doi></cross_references></HashMap>